MVMDF (Mountain Valley MD Holdings) Gross Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mountain Valley MD Holdings Gross Margin %?

Mountain Valley MD Holdings MVMDF +3.64% Gross Margin % is 0.00% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 943 Drug Manufacturers companies, Mountain Valley MD Holdings ranks worse than 106044.43% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Mountain Valley MD Holdings's Gross Profit for the three months ended in Mar. 2026 was $0.02 Mil. Mountain Valley MD Holdings's Revenue for the three months ended in Mar. 2026 was $0.02 Mil. Therefore, Mountain Valley MD Holdings's Gross Margin % for the quarter that ended in Mar. 2026 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Mountain Valley MD Holdings's Gross Margin % or its related term are showing as below:


During the past 7 years, the highest Gross Margin % of Mountain Valley MD Holdings was 63.64%. The lowest was 63.64%. And the median was 63.64%.

MVMDF's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54
* Ranked among companies with meaningful Gross Margin % only.

Mountain Valley MD Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mountain Valley MD Holdings was 0.00% per year.


Mountain Valley MD Holdings  (OTCPK:MVMDF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mountain Valley MD Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mountain Valley MD Holdings Gross Margin % Related Terms


Mountain Valley MD Holdings Gross Margin % Historical Data

* Premium members only.

The historical data trend for Mountain Valley MD Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mountain Valley MD Holdings Gross Margin % Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Gross Margin %
Get a 7-Day Free Trial 63.22 0.00 0.00 0.00 0.00

Mountain Valley MD Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MVMDF vs ZTS: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's Gross Margin % falls into.



Mountain Valley MD Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Mountain Valley MD Holdings's Gross Margin for the fiscal year that ended in Mar. 2026 is calculated as

Gross Margin % (A: Mar. 2026 )=Gross Profit (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=0 / 0.047
=(Revenue - Cost of Goods Sold) / Revenue
=(0.047 - 0) / 0.047
=N/A %

Mountain Valley MD Holdings's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=0 / 0.019
=(Revenue - Cost of Goods Sold) / Revenue
=(0.019 - 0) / 0.019
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Mountain Valley MD Holdings (MVMDF) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Mountain Valley MD Holdings and its competitors. Over the past decade, Mountain Valley MD Holdings' Gross Margin % has ranged from 63.64 to 63.64. According to the industry distribution chart, Mountain Valley MD Holdings ranks #999999 out of 943 companies in the Drug Manufacturers industry.
Is Mountain Valley MD Holdings' Gross Margin % too high?
Mountain Valley MD Holdings' current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 63.64 to a high of 63.64. Based on the distribution chart, Mountain Valley MD Holdings ranks #999999 out of 943 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Mountain Valley MD Holdings' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mountain Valley MD Holdings ranks #999999 out of 943 companies for Gross Margin %. This places Mountain Valley MD Holdings in the lower half of its industry. The industry median Gross Margin % is 48.54. Historically, Mountain Valley MD Holdings' own Gross Margin % has ranged from 63.64 to 63.64 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Mountain Valley MD Holdings and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mountain Valley MD Holdings's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mountain Valley MD Holdings stock overvalued right now?
Mountain Valley MD Holdings (MVMDF) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Mountain Valley MD Holdings (MVMDF), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mountain Valley MD Holdings Business Description

Other Exchanges 20MP:GermanyMVMD:Canada
Address 260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.